13F Data
13F filer · CIK 2018299

Boxer Capital Management, LLC

San Diego, CA · filing since Q4 2024 · last filing Aug 14, 2026
Reported value
$1.3B
+$566.1M vs prior
Positions
63
New / sold out
12 / 3
Added / reduced
17 / 1
Turnover
2.8%
buys $339.9M · sells $29.4M
Top-10 weight
65.1%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedABIVAX SA+405,000+202.5%+$54.0M
NewQ32 BIO INC+3,149,310–+$40.1M
AddedUNIQURE NV+841,300+127.1%+$38.8M
AddedREPLIMUNE GROUP INC+2,808,000+239.0%+$31.1M
AddedCELCUITY INC+191,530+85.1%+$20.0M
AddedCAPRICOR THERAPEUTICS INC+805,156+136.5%+$19.4M
AddedDEFINIUM THERAPEUTICS INC+400,000+66.8%+$18.8M
AddedKYMERA THERAPEUTICS INC+100,000+30.4%+$11.5M
AddedPRECIGEN INC+1,650,000+47.1%+$9.4M
AddedOCULAR THERAPEUTIX INC+950,000+271.4%+$9.3M
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outTERNS PHARMACEUTICALS INC-375,000-100.0%$-19.8M
Sold outSOLENO THERAPEUTICS INC-200,000-100.0%$-6.7M
ReducedALLOGENE THERAPEUTICS INC-1,225,000-45.0%$-2.5M
Sold outKALVISTA PHARMACEUTICALS INC-20,400-100.0%$-410.7K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $1.2BQ1 2025: $332.5MQ2 2025: $198.7MQ3 2025: $313.7MQ4 2025: $456.9MQ1 2026: $761.7MQ2 2026: $1.3B
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1TANGO THERAPEUTICS INCCOM10,876,219$340.0M25.61%
2REVOLUTION MEDICINES INCCOM500,000$93.6M7.05%
3ABIVAX SASPONSORED ADS605,000$80.6M6.07%
4UNIQURE NVSHS1,503,300$69.2M5.21%
5KODIAK SCIENCES INCCOM1,477,600$57.6M4.34%
6KYMERA THERAPEUTICS INCCOM429,100$49.2M3.71%
7DEFINIUM THERAPEUTICS INCCOM SHS998,500$47.0M3.54%
8REPLIMUNE GROUP INCCOM3,983,000$44.1M3.32%
9CELCUITY INCCOM416,530$43.6M3.28%
10Q32 BIO INCCOM3,149,310$40.1M3.02%
53 more rows. Subscribe for $29/month to see every row, download the data and use the API.